The University of Texas Medical Branch at Galveston | Industry Collaboration Index

Review The University of Texas Medical Branch at Galveston's industry research evidence before publication on 15 October.

Edition 1 is built entirely from the open scholarly record. Further down this page: how many of this university's candidate company links were verified, and how many were set aside and why. Factual corrections and researcher opt-outs are accepted until 17:00 BST on Tuesday 13 October (16:00 UTC): send a correction.

The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition.

Where it works with industry

Leading sectors of its industry work

Pharmaceuticals and Therapeutics
Medical Technology and Digital Health
Biotechnology and Advanced Therapies
Advanced Materials and Nanotechnology
Climate, Environment and Sustainability

At launch

What this page will show on 15 October

Its world, regional and national position, with a rank range.
Four pillars: co-creation, durability, scale and breadth.
Its leading company partners and its position in each sector index.

How this profile was checked (free)

491 of 820 candidate company links verified

Links set aside, by reason:

157 company name not written in the author's affiliation
50 ordinary-word name without a company suffix
33 part of a university or public institute's own unit
20 a place or common word that failed its stricter rule
15 excluded after hand audit
9 excluded after hand audit
45 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

A link is one work, this university and one company. If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, The University of Texas Medical Branch at Galveston ranks #815 of 1,195.

View the RCI profile →

The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.